RFI - Human Poison Exposure Data

Closed Pre-Solicitation Posted

Solicitation number
FDA-RFI-75F40124Q00218
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

PSC
Not on record
Place of performance
Silver Spring, Maryland 20903, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration (FDA)/Center for Drug Evaluation and Research (CDER) is seeking access to nationwide human poison exposure data that targets the segment of the population who rely exclusively on the internet for health information. The primary objective is to complement the existing data in support of the agency's public health surveillance activities. The FDA is interested in obtaining access to a well-structured, user-friendly web-based platform that provides comprehensive triage and follow-up of poison exposure cases, with real-time data access, analytics, and reporting capabilities. Interested vendors should demonstrate their experience and capability to meet the stated requirements, including the ability to provide technical support, training, data analysis, and subject matter expertise services. Responses to this Request for Information (RFI) are due by May 6, 2024, but no contract award will be made based on the responses.

This opportunity is not set-aside for any specific business type. The relevant NAICS code is likely to be in the professional, scientific, and technical services sector, but the specific code is not provided. There is no information on potential incumbents or current contractors, award values, or budget ranges. The key numerical detail is the due date for responses to the RFI.

Notice text

The Food and Drug Administration (FDA)/Center for Drug Evaluation and Research (CDER) is interested in obtaining access to human poison exposure data collected exclusively online. This data targets a segment of the population who may exclusively rely on the internet for health information. The primary objective of securing access to exposure data targeting this population, is to complement the existing data in support of the agency’s public health surveillance activities.

**See attachment FDA_RFI_75F40124R00011 for full details and information.

Files

File Type Posted
FDA_SourcesSought.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity